Related Experiment Video

Updated: Sep 12, 2026

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

Proteasomal targeting of a viral oncogene abrogates oncogenic phenotype and enhances immunogenicity

Judy Tellam1, Geoff Connolly, Natasha Webb

  • 1Queensland Institute of Medical Research, Bancroft Centre, 300 Herston Rd, Brisbane, Australia 4029.

Blood
|August 16, 2003
PubMed

Insights

Targeting oncogenes like Epstein-Barr virus's latent membrane protein 1 (LMP1) with ubiquitination can reduce cancer-causing activity and improve immune response, offering new cancer immunotherapy strategies.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Viral and mutated oncogenes are difficult to use in cancer immunotherapy due to their cancer-promoting activity and weak immune response.
  • Latent membrane protein 1 (LMP1) from Epstein-Barr virus is a model oncogene with these limitations.

Purpose of the Study:

  • To develop a novel strategy to deactivate oncogenic signaling pathways and enhance immunogenicity of oncogenes.
  • To investigate the therapeutic potential of targeting LMP1 using proteasomal degradation pathways.

Main Methods:

  • Cotranslational ubiquitination and N-end rule targeting were used to enhance intracellular degradation of LMP1.
  • NF-kappaB and STAT signaling pathways were analyzed in human cells expressing modified LMP1.
  • Tumorigenicity of murine cells expressing LMP1 was assessed, and immune responses were evaluated after immunization with ubiquitinated LMP1.

Main Results:

  • Cotranslational ubiquitination and N-end rule targeting led to enhanced LMP1 degradation and complete blockade of NF-kappaB and STAT activation.
  • Ubiquitin linkage to LMP1 abrogated tumorigenicity in murine cells.
  • Immunization with ubiquitinated LMP1 enhanced CD8+ T cell responses.

Conclusions:

  • Proteasomal targeting of tumor-associated oncogenes is a promising strategy for cancer therapy.
  • This approach can be applied through gene therapy or vaccination to overcome oncogene-induced tumorigenesis and enhance anti-tumor immunity.

More Related Videos

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...